23 April 2026
23 April 2026
Designed for diagnostic radiology and RT, the Rembra platform extends CT imaging capability to more connected workflows.
The trial includes dose-escalation and dose-expansion segments.
The initiative will combine MSD’s scientific and data expertise with Google Cloud’s AI and cloud technology.
The ArteraAI prostate biopsy assay predicts the risk of prostate cancer progression.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
